|
 << Page 3 of 3
Global pharmaceutical market growth accelerates to
11% in 1999
Leading products
Looking at the total audited
world market, AstraZeneca's Losec remains the top-selling
drug, with $5.7 billion in 1999 sales and 17% growth,
down from the 35% growth recorded in 1998. The continued
success of Merck & Co's cholesterol-lowering drug
Zocor (simvastatin) made it the second most sold drug
in 1999, with $3.9 billion in sales and 11% growth.
Of the top ten selling drugs, Warner-Lambert and Pfizer's
cholesterol drug Lipitor (atorvastatin) enjoyed the largest
year-over-year growth in sales, with 66% growth and $3.8
billion in sales.
Overall, the fastest growing product worldwide was Sanofi-Synthelabo
and Bristol-Myers Squibb's anti-stroke drug Plavix (clopidogrel),
which enjoyed a 329% increase year-over-year and $598
million in sales. Plavix was ranked 69th in worldwide
audited 1999 sales. Johnson & Johnson's anti-infective
drug Levaquin (levofloxacin), ranked 54th in worldwide
sales, was the second-fastest growing drug in 1999, with
101% growth.
|
Leading
products in 1999 global pharmaceutical sales
|
|
Rank
|
Product
|
1999 Sales
US$Bn
|
% Global Sales
|
% Growth Year-on-Year*
|
|
1
|
Losec |
5.7
|
1.9%
|
17%
|
|
2
|
Zocor |
3.9
|
1.3%
|
11%
|
|
3
|
Lipitor |
3.8
|
1.3%
|
66%
|
|
4
|
Norvasc |
3.0
|
1%
|
17%
|
|
5
|
Prozac |
2.9
|
1%
|
4%
|
|
6
|
Ogastro |
2.3
|
0.8%
|
65%
|
|
7
|
Seroxat |
2.1
|
0.7%
|
17%
|
|
8
|
Zoloft |
2.0
|
0.7%
|
12%
|
|
9
|
Claritine |
2.0
|
0.7%
|
22%
|
|
10
|
Zyprexa |
1.9
|
0.6%
|
42%
|
Source: IMS HEALTH
World Review
2000 (*Growth measured in Local Currency Dollars)
Detailed
reports of sales for the Top 20 Corporations,
Products,
Countries
and Therapy
Areas in 1998 and 1999 are available to buy online.
See also: The global
pharmaceutical market report for 1998
For
full explanation of figures and collection methods see
Data Value and definitions
Copyright IMS HEALTH, 2 June 2000
|